Thromboembolism's Impact On Stroke Patients: Understanding The Risk

Thromboembolism is a common complication in stroke patients and can lead to pulmonary embolism, which is responsible for 13-25% of early deaths after stroke. The risk of thromboembolism is particularly high during the first three months after a stroke, with immobilization and infection being the main contributors to the risk. The risk factors for thromboembolism in stroke patients include advanced age, high National Institute of Health Stroke Scale score, hemiparesis, immobility, female gender, and atrial fibrillation. The current diagnostic paradigm for thromboembolism is reactive rather than proactive, which can lead to sudden death from pulmonary embolism. Treatment for thromboembolism is highly effective in preventing morbidity and mortality, and low-dose anticoagulant therapy is recommended for ischemic stroke.

The risk of deep vein thrombosis (DVT) in stroke patients

Deep vein thrombosis (DVT) is a serious complication for stroke patients, and it can lead to the devastating consequence of a pulmonary embolism. The risk of DVT in acute stroke patients is between 10-75%, depending on the diagnostic method and time of evaluation. The onset of DVT development after a stroke can be as early as the second day, peaking between days 2 and 7. If left untreated, proximal DVT has a 15% risk of death. The risk factors for DVT in acute stroke patients include advanced age, high National Institute of Health Stroke Scale (NIHSS) score, hemiparesis, immobility, female gender, atrial fibrillation, receipt of intravenous or intra-arterial tissue plasminogen activator (TPA), and admission to an academic hospital. The initial test of choice for diagnosing peripheral venous thrombosis is ultrasound due to its accuracy, low cost, portability, and safety. In addition, Doppler techniques provide direct information regarding flow physiology. The treatment options for DVT in stroke patients include both pharmacological and physical methods.

The risk of pulmonary embolism (PE) in stroke patients

The risk of developing a PE after a stroke can be reduced by the use of anticoagulants, such as low-molecular-weight heparins, which have been shown to reduce the occurrence of DVTs after acute ischemic strokes. However, the use of anticoagulants also increases the risk of bleeding, and the balance of risks and benefits must be carefully considered.

Other methods of preventing PE in stroke patients include the use of pneumatic sequential compression devices and elastic stockings. However, there is insufficient evidence to support the routine use of physical methods for preventing PE in acute stroke patients.

The risk of DVT and PE in stroke patients with atrial fibrillation

The risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) is increased in stroke patients with atrial fibrillation. In patients with acute hemiplegic stroke, studies have shown an incidence of DVT of approximately 50% within 2 weeks in the absence of heparin prophylaxis, with the majority of these affecting the paralysed leg and being asymptomatic. The risk of DVT is greater in older patients and those with atrial fibrillation.

The main clinical significance of asymptomatic proximal DVT is its potential to cause fatal PE, which accounts for 13-25% of early deaths after stroke. The risk of fatal PE associated with untreated subclinical DVT is lower, though it remains significant. In patients with proximal subclinical DVT, the risk of clinical PE is 35%.

In patients with acute ischaemic stroke, a reduction of venous thromboembolic events was noted when low-molecular-weight heparins were used. However, this slightly increased the risk of extracranial bleeding. The combined death and disability rates were reduced with the use of LMWH but could increase complications related to haemorrhage.

The risk of DVT and PE in stroke patients with immobility

The Risk of DVT and PE in Stroke Patients with Immobilisation

Stroke patients with immobility are at a high risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is a serious complication in stroke patients and may lead to the devastating consequence of a pulmonary embolism. The incidences of DVTs in immobilised post-stroke patients vary from 10-75%, depending on the diagnostic method and time of evaluation. The risk of DVT in acute stroke patients is greater in those with advanced age, high National Institute of Health Stroke Scale (NIHSS) score, hemiparesis, female gender, atrial fibrillation, receipt of intravenous or intra-arterial tissue plasminogen activator (TPA), and admission to an academic hospital.

The risk of DVT and PE is particularly high during the first three months after stroke. In the first few months after a stroke, the incidence of PE usually ranges from 1-3%. PE accounts for 13-25% of early deaths after stroke.

The risk of DVT and PE in stroke patients with pneumonia

Pneumonia is a common complication after a stroke, and it is one of the leading medical complications. Pneumonia and pulmonary embolism (PE) can occur together, but the possibility of coexistent PE in a patient with strong clinical evidence of pneumonia is rarely considered.

Stroke patients are at a high risk of deep vein thrombosis (DVT) and PE, with the risk of DVT being as high as 50% within the first two weeks after a stroke. The risk of DVT is greater in older patients and those with atrial fibrillation.

The risk factors for DVT in acute stroke are advanced age, high National Institute of Health Stroke Scale (NIHSS) score, hemiparesis, immobility, female gender, atrial fibrillation, receipt of intravenous or intra-arterial tissue plasminogen activator (TPA), and admission to an academic hospital.

The risk of VTE is particularly high during the first three months after a stroke. Data from the Tromsø Study revealed a 20- and 11-fold increased risk of VTE in the first and subsequent two months after an ischemic stroke, respectively, with a rapid decline in the risk estimates thereafter.

In conclusion, stroke patients with pneumonia are at an increased risk of DVT and PE due to immobilization and infection. The risk of VTE is highest in the first three months after a stroke and declines rapidly thereafter.

Frequently asked questions